Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Abnormal Protein at Site of Inflammation
- Molecular classification
- Protein, Cytokine, Enzyme
01
Overview
The term "Abnormal Protein at Site of Inflammation" refers to a collection of proteins that are either produced in excess, structurally altered, or deposited abnormally in tissues as a result of an inflammatory process. These proteins, such as CRP and SAA, serve as biomarkers for inflammation and may also play a direct role in disease pathology. Their detection is central for diagnosis, monitoring, and guiding therapy across many medical specialties.
- Other names
- Acute phase proteinsC-reactive protein (CRP)Serum amyloid A (SAA)Amyloid fibrilsInflammatory cytokines (IL-1β, IL-6, TNFα)Matrix metalloproteinases (MMPs)
02
Mechanism of action
Varies depending on the specific protein and therapeutic agent. Includes suppression of inflammatory cytokine production, inhibition of immune cell activity, and direct targeting of abnormal protein deposition.
03
Biological functions
Immune responseInflammationAcute phase responseTissue remodeling
04
Disease associations
InflammationAutoimmune disordersInfectionChronic diseasesAmyloidosisCancer
05
Safety considerations
Systemic inflammatory response syndrome (SIRS)AA amyloidosis (organ dysfunction due to amyloid deposition)Drug-related side effects (e.g., immunosuppression)Risk of infectionExacerbation of underlying conditions
06
Interacting drugs
Anti-inflammatory drugs (e.g., corticosteroids, NSAIDs)
2 more in the full profile.
07
Biomarkers
C-reactive protein (CRP)High-sensitivity C-reactive protein (hsCRP)Erythrocyte sedimentation rate (ESR)Plasma viscositySerum amyloid A (SAA)Amyloid deposits (tissue biopsy)
Beyond the preview
Go deeper on Abnormal Protein at Site of Inflammation.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Abnormal Protein at Site of Inflammation.